Kyntra Bio (KYNB) Price to Sales (2014 - 2026)

Kyntra Bio has disclosed Price to Sales across 13 years of filings, most recently posting 20.74 for Q2 2026.

• In Q2 2026, Price to Sales rose 30.44% year-over-year to 20.74; the TTM figure through Jun 2026 stood at 4.04 (up 38.48% YoY), while the FY2025 annual figure was 5.52, up 205.84% from the prior year.
• Price to Sales came in at 20.74 for Q2 2026 at Kyntra Bio, up from 7.34 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 327.22 in Q3 2024 to a low of 1.19 in Q4 2023.
• Average Price to Sales over 5 years is 52.12, with a median of 19.59 recorded in 2022.
• Year-over-year, Price to Sales tumbled 100.66% in 2023 and surged 15375.7% in 2024.
• Over 5 years, Price to Sales stood at 179.59 in 2022, then slumped by 100.66% to 1.19 in 2023, then surged by 1537.19% to 17.05 in 2024, then soared by 63.24% to 27.83 in 2025, then dropped by 25.46% to 20.74 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 20.74 in Q2 2026, 7.34 in Q1 2026, and 27.83 in Q4 2025.